These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27920522)

  • 1. Incorporation of heparin-binding proteins into preformed dextran sulfate-chitosan nanoparticles.
    Zaman P; Wang J; Blau A; Wang W; Li T; Kohane DS; Loscalzo J; Zhang YY
    Int J Nanomedicine; 2016; 11():6149-6159. PubMed ID: 27920522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of SDF-1α-chitosan-dextran sulfate nanoparticles.
    Bader AR; Li T; Wang W; Kohane DS; Loscalzo J; Zhang YY
    J Vis Exp; 2015 Jan; (95):52323. PubMed ID: 25650558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A crosslinked dextran sulfate-chitosan nanoparticle for delivery of therapeutic heparin-binding proteins.
    Guarino VA; Blau A; Alvarenga J; Loscalzo J; Zhang YY
    Int J Pharm; 2021 Dec; 610():121287. PubMed ID: 34775044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles.
    Wang B; Tan L; Deng D; Lu T; Zhou C; Li Z; Tang Z; Wu Z; Tang H
    Int J Nanomedicine; 2015; 10():3417-27. PubMed ID: 26056441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats.
    Yin T; Bader AR; Hou TK; Maron BA; Kao DD; Qian R; Kohane DS; Handy DE; Loscalzo J; Zhang YY
    Biomacromolecules; 2013 Nov; 14(11):4009-20. PubMed ID: 24059347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ controlled release of stromal cell-derived factor-1α and antimiR-138 for on-demand cranial bone regeneration.
    Wu G; Feng C; Quan J; Wang Z; Wei W; Zang S; Kang S; Hui G; Chen X; Wang Q
    Carbohydr Polym; 2018 Feb; 182():215-224. PubMed ID: 29279118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable nanoparticles/hydrogels composite as sustained release system with stromal cell-derived factor-1α for calvarial bone regeneration.
    Mi L; Liu H; Gao Y; Miao H; Ruan J
    Int J Biol Macromol; 2017 Aug; 101():341-347. PubMed ID: 28330754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and Characterization of Mucoadhesive Buccal Nanoparticles Using Chitosan and Dextran Sulfate.
    Suh JW; Lee JS; Ko S; Lee HG
    J Agric Food Chem; 2016 Jul; 64(26):5384-8. PubMed ID: 27222213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal cell-derived factor-1α-encapsulated albumin/heparin nanoparticles for induced stem cell migration and intervertebral disc regeneration in vivo.
    Zhang H; Yu S; Zhao X; Mao Z; Gao C
    Acta Biomater; 2018 May; 72():217-227. PubMed ID: 29597025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor.
    Huang M; Vitharana SN; Peek LJ; Coop T; Berkland C
    Biomacromolecules; 2007 May; 8(5):1607-14. PubMed ID: 17428030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing chitosan-dextran sulfate nanoparticles using charge ratios.
    Chen Y; Mohanraj VJ; Wang F; Benson HA
    AAPS PharmSciTech; 2007 Nov; 8(4):E98. PubMed ID: 18181558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.
    Chaiyasan W; Srinivas SP; Tiyaboonchai W
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):200-7. PubMed ID: 23356788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoglycan complex formulation extends VEGF retention time in the lung.
    Lauten EH; VerBerkmoes J; Choi J; Jin R; Edwards DA; Loscalzo J; Zhang YY
    Biomacromolecules; 2010 Jul; 11(7):1863-72. PubMed ID: 20575564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immune response against pertussis toxoid by IgA-loaded chitosan-dextran sulfate nanoparticles.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2012 Jan; 101(1):233-44. PubMed ID: 21953499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP-2 encapsulated polysaccharide nanoparticle modified biphasic calcium phosphate scaffolds for bone tissue regeneration.
    Wang Z; Wang K; Lu X; Li M; Liu H; Xie C; Meng F; Jiang O; Li C; Zhi W
    J Biomed Mater Res A; 2015 Apr; 103(4):1520-32. PubMed ID: 25100662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the complexation of polysaccharides into multi-functional colloidal assemblies for nanomedicine.
    Costalat M; Alcouffe P; David L; Delair T
    J Colloid Interface Sci; 2014 Sep; 430():147-56. PubMed ID: 24998067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and Characterization of Mucoadhesive Nanoparticles for Enhancing Cellular Uptake of Coenzyme Q10.
    Lee JS; Suh JW; Kim ES; Lee HG
    J Agric Food Chem; 2017 Oct; 65(40):8930-8937. PubMed ID: 28933847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.
    Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW
    Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan-dextran sulfate nanoparticles enhances their expression and anti-cancer effects.
    Perumal V; Arfuso F; Chen Y; Fox S; Dharmarajan AM
    Mol Cell Biochem; 2018 Jun; 443(1-2):205-213. PubMed ID: 29185158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.